• Info
  • Insider Trading

Insider Transactions Reported by 23 Insiders of GENOCEA BIOSCIENCES, INC.

Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 12 Feb 2025

GENOCEA BIOSCIENCES, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William D. Clark President and CEO, Director $380,471 02 Jun 2022
Jessica Baker Flechtner Chief Scientific Officer $111,284 02 Jun 2022
Diantha Duvall Chief Financial Officer $94,235 02 Jun 2022
Girish N. Aakalu Chief Business Officer $93,074 04 Apr 2022
Thomas Andrew Davis Chief Medical Officer $85,413 04 Apr 2022
RAYMOND D. STAPLETON JR Chief Technology Officer $54,688 25 May 2022
Jacquelyn Sumer Chief Legal & Compliance Off $53,750 01 Jun 2022
George Siber Director $315 27 May 2022
KENNETH BATE Director 01 Jul 2021
Ali Behbahani Director, 10%+ Owner 24 May 2022
Carmen Chang 10%+ Owner 24 May 2022
Mohamad Makhzoumi 10%+ Owner 24 May 2022
Scott D. Sandell 10%+ Owner 24 May 2022
Paul Edward Walker 10%+ Owner 24 May 2022
Gisela Schwab Director 01 Jul 2021
Michael J. Higgins Director 01 Jul 2021
Katrine Bosley Director 01 Jul 2021
John Lunger Director 03 Mar 2022
Anthony A. Florence Jr. 10%+ Owner 24 May 2022
Jennifer Lyn Herron Director 09 Sep 2021
Peter W. Sonsini 10%+ Owner 24 May 2022
New Enterprise Associates 16, L.P. 10%+ Owner 24 May 2022
FOREST BASKETT 10%+ Owner 24 May 2022

Recent Insider Transactions by Companies or Individuals for GENOCEA BIOSCIENCES, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.